Investor Stock List
Ranked #3,106 of 8,699 institutional investors

Atlas Venture Life Science Advisors, LLC

Cambridge, MA

$641M
US stock portfolio at live prices · today −$15.3M (−2.33%)
Live prices, last trade 12:21 PM ET
Value at quarter end (Q3 2026)
$631M
Change from Q2 2026
−$250.1M (−28.38%)
Positions
9 · 2 new, 0 sold out
Filed
Nov 10, 2026

Holdings

Q3 2026 13F, live prices
KYMR 51.4%IRON 16.1%KLRA 9.24%DYN 8.47%OBX 8.39%
StockSharesValue, live% of portfoliovs Q2 2026
KYMR Kymera Therapeutics, Inc.2,847,541$329M51.4%Unchanged
IRON Disc Medicine, Inc.1,384,025$103M16.1%Reduced −9%
KLRA Kailera Therapeutics, Inc.5,171,282$59.3M9.24%Unchanged
DYN Dyne Therapeutics, Inc.3,440,720$54.3M8.47%Reduced −49%
OBX Obsidian Therapeutics, Inc.4,503,149$53.8M8.39%New
QTTB Q32 Bio Inc.2,717,106$22.9M3.57%Unchanged
KRRO Korro Bio, Inc.773,260$9.6M1.49%Reduced −20%
SION Sionna Therapeutics, Inc.2,995,602$8.6M1.34%Unchanged
ODTX Odyssey Therapeutics, Inc.2,692$46K<0.1%New